Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.95 is 93% above its 5-year average of -27.21, near the high end of its 5-year range (-56.42–-1.95).
23.83% above its 12-month average of -2.56.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.41.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.95
EARNINGS PER SHARE (EPS) AVG TTM
-2.56
EARNINGS PER SHARE (EPS) AVG 3Y
-13.27
EARNINGS PER SHARE (EPS) AVG 5Y
-27.21
EARNINGS PER SHARE (EPS) AVG 10Y
-61.21
EARNINGS PER SHARE (EPS) AVG 15Y
-79.60
EARNINGS PER SHARE (EPS) AVG 20Y
-105.48
CURRENT VS TTM AVG
+23.83%
CURRENT VS 3Y AVG
+85.30%
CURRENT VS 5Y AVG
+92.83%
CURRENT VS 10Y AVG
+96.81%
CURRENT VS 15Y AVG
+97.55%
CURRENT VS 20Y AVG
+98.15%
Alaunos Therapeutics, Inc.
Market Cap
$1.79M
Earnings Per Share (EPS)
-1.95
TTM Avg
-2.56
3Y Avg
-13.27
5Y Avg
-27.21
Market Cap
$1.82M
Earnings Per Share (EPS)
-50.69
TTM Avg
-49.87
3Y Avg
-19185.19
5Y Avg
-12947.08
Market Cap
$1.85M
Earnings Per Share (EPS)
-46.30
TTM Avg
-226.80
3Y Avg
-2352.88
5Y Avg
-5539.80
Market Cap
$1.87M
Earnings Per Share (EPS)
-213.25
TTM Avg
-232.07
3Y Avg
-150.88
5Y Avg
-127.10
Market Cap
$1.91M
Earnings Per Share (EPS)
-46.49
TTM Avg
-92.15
3Y Avg
-143.14
5Y Avg
-171.91
Market Cap
$1.93M
Earnings Per Share (EPS)
-53.60
TTM Avg
-139.70
3Y Avg
-437.70
5Y Avg
-488.64
Market Cap
$1.63M
Earnings Per Share (EPS)
-5.35
TTM Avg
-12.67
3Y Avg
-17.25
5Y Avg
-14.07
Market Cap
$1.51M
Earnings Per Share (EPS)
-10.02
TTM Avg
-4.85
3Y Avg
-7.18
5Y Avg
-7.18
Market Cap
$1.47M
Earnings Per Share (EPS)
-1815.30
TTM Avg
-34855.30
3Y Avg
-136953.83
5Y Avg
-91453.81
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | $1.79M | -1.95 | -2.56 | -13.27 | -27.21 |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.82M | -50.69 | -49.87 | -19185.19 | -12947.08 |
| Tenon Medical, Inc. (TNON)vs › | $1.85M | -46.30 | -226.80 | -2352.88 | -5539.80 |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.87M | -213.25 | -232.07 | -150.88 | -127.10 |
| Autonomix Medical, Inc. (AMIX)vs › | $1.91M | -46.49 | -92.15 | -143.14 | -171.91 |
| Beyond Air, Inc. (XAIR)vs › | $1.93M | -53.60 | -139.70 | -437.70 | -488.64 |
| Silo Pharma, Inc. (SILO)vs › | $1.63M | -5.35 | -12.67 | -17.25 | -14.07 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.51M | -10.02 | -4.85 | -7.18 | -7.18 |
| PMGC Holdings Inc. (ELAB)vs › | $1.47M | -1815.30 | -34855.30 | -136953.83 | -91453.81 |
| Curis, Inc. (CRIS)vs › | $1.46M | -14.22 | -74.60 | -142.80 | -169.23 |
Trailing EPS (TTM)
$-1.95
Forward EPS (Est.)
$-21.00
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.20 |
| 2024-12-31 | -2.92 |
| 2023-12-31 | -21.97 |
| 2022-12-31 | -25.97 |
| 2021-12-31 | -53.80 |
| 2020-12-31 | -56.42 |
| 2018-12-31 | -55.52 |
| 2017-12-31 | -59.50 |
| 2016-12-31 | -190.15 |
| 2015-12-31 | -143.63 |
| 2014-12-31 | -47.14 |
| 2013-12-31 | -99.67 |
| 2012-12-31 | -183.58 |
| 2011-12-31 | -144.94 |
| 2010-12-31 | -106.52 |
| 2009-12-31 | -49.65 |
| 2008-12-31 | -178.25 |
| 2007-12-31 | -211.94 |
| 2006-12-31 | -213.06 |
| 2005-12-31 | -262.83 |
| 2004-12-31 | -39.44 |
| 2003-12-31 | -18.31 |
| 2002-12-31 | -26.73 |
| 2001-12-31 | -48.55 |
